LakePharma, a U.S.-based biologics contract research, development, and manufacturing organization (CRDMO), has launched its new Vector Center, which offers a range of services including viral vector construction, CAR-T and stable cell line engineering, preclinical process development, scale-up production, and analytical development. Three viral production systems—lentivirus, adeno-associated virus (AAV), and baculovirus—are available. The center is located in Worcester, MA, which is in close pro...